GLP-1 RAs contribute to this management strategy by supporting weight reduction and maintaining stable glucose levels with minimal risk of hypoglycemia—an important factor in preserving physical strength and overall resilience during cancer therapy [93]. Here, GLP1R is linked to cancer.